NCT05765851 - A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Advanced Solid TumorBreast Cancer

Interventions

DRUG

DS-1103a

One IV infusion Q3W on Day 1 of each 21-day cycle

DRUG

T-DXd

One IV infusion Q3W on Day 1 of each 21-day cycle

Trial Locations (8)

Hospital Universitari Vall d'Hebron, Barcelona

NEXT Oncology, Fairfax

Oncopole - Institut Claudius Regaud, Toulouse

Florida Cancer Specialists, Sarasota

Centre Léon Bérard, Lyon

University of Utah, Salt Lake City

Lifespan Cancer Institute, Providence

Princess Margaret Cancer Centre, University Health Network, Toronto